Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
2010-11-25
Original market date: See footnote 1
2004-12-07
Product name:
PHL-SODIUM POLYSTYRENE SULFONATE RETENTION ENEMA
DIN:
02261669 Electronic product monograph is not available
Company:
PHARMEL INC
6111, Avenue Royalmount, Suite 100
Montreal
Quebec
Canada
H4P 2T4
Class:
Human
Dosage form(s):
Suspension
Route(s) of administration:
Rectal
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
40:18.18
Anatomical Therapeutic Chemical (ATC): See footnote 4
V03AE01 POLYSTYRENE SULPHONATE
Active ingredient group (AIG) number:See footnote5
0108701001
Active ingredient(s) | Strength |
---|---|
SODIUM POLYSTYRENE SULFONATE | 250 MG / ML |